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Summary.-The morphology of 20 mammary adenocarcinomas induced by 7,12-
dimethylbenz(a)anthracene (DMBA) in Sprague-Dawley rats was compared with
their growth characteristics and oestrogen-binding capacity following ovariectomy.
The capacity to bind (3H)oestradiol-17B did not appear to be related to the growth
characteristics, time of appearance after DMBA administration, or time between
ovariectomy and assay for specific oestrogen-binding proteins. Furthermore,
different tumours appeared to have oestrogen-binding capacities unrelated to the
percentage of neoplastic cells within the tumour, amount of inflammation, mast
cell infiltration, or the presence of fluid-filled cysts. The only morphological
features which appeared to be correlated with oestrogen-binding capacity were
the number of mitoses and the lipid content of the tumour; that is, the oestrogen-
binding capacity tended to be lower in tumours with moderate or large numbers
of mitoses and in tumours with much lipid in the epithelial cells.
Six of the 19 adenocarcinomas found prior to sacrifice either continued growing
or remained static following ovariectomy, while the others underwent regression.
In 5 of the regressing tumours a new growth phase was observed, usually beginning
2 months after ovariectomy. Tumours other than mammary adenocarcinomas
present in the animals evaluated, included an extra-osseous osteosarcoma as well
as fibroadenomas and Zymbal-gland tumours.
MAMMARY tumours induced in
rats by 7,12-dimethylbenz(a)anthracene
(DMBA) have been the focus of extensive
investigation because of some similarities
between these rodent tumours and human
breast cancer (e.g. histological hetero-
geneity, existence of both ovary-depen-
dent and ovary-independent tumours,
presence of specific oestrogen-binding pro-
teins). A number ofattempts to correlate
the morphology of DMBA-induced tu-
mours with certain parameters of tumour
growth and biochemistry have met with
variable success (Archer and Orlando,
1968; Daniel and Pritchard, 1967; De-
Sombre, Anderson and Kang, 1975; Hilf
et al., 1970; Stevens, Stevens and Currie,
1965; Young, Cowan and Sutherland,
1963). Oestrogen-binding proteins have
been demonstrated and characterized in
the normal mammary gland (Beers and
Wittliff, 1973; Wittliff et al., 1972) and
in ovary-dependent DMBA-induced mam-
mary tumours of the rat (Boylan and
Wittliff, 1975; DeSombre et al., 1976;
Kyser, 1970; McGuire and Julian, 1971).
Earlier we reported that many mammary
tumours whose growth was ovary-inde-
pendent contained specific oestrogen-bind-
ing proteins (Boylan and Wittliff, 1975)
but no relationship between this para-
meter and tumour morphology or growth
was presented. It is the intent of this
paper to demonstrate and correlate someDMBA-INDUCED MAMMARY TUMOURS IN RATS
of the variable biological and biochemical
parameters which exist among these
chemically induced tumours. In demon-
strating the diversity found among
DMBA-induced tumours with respect to
a number of parameters, we want to
promote awareness ofthe hazards involved
inthe common practice ofpooling tumours
for biochemical assays.
MATERIALS AND METHODS
Tumours were induced in female Sprague-
Dawley rats (Charles River Laboratories,
Wilmington, Mass.) by gastric intubation of
5 mg DMBA (Sigma Chemical Co., St.
Louis, Mo.) dissolved in 1 ml sesame-seed oil
administered weekly for 5 weeks (total dose:
25 mg) beginningf when the animal was 49
days old. Four weeks after the final in-
tubation, weekly palpations were begun on
each rat; the time of appearance, position,
and average diameter (measured with calipers
through the skin) of all tumours were re-
corded. To eliminate fluctuating oestrogen
levels, which interfere with determination
of the oestrogen-binding capacity (OBC),
bilateral ovariectomy was performed under
ether anaesthesia at least 3 days before
sacrifice and assay.
The animals were killed by cervical
dislocation after light ether anaesthesia;
tumours were excised and immersed immedi-
ately in ice-cold Tris-EDTA buffer (10 mM
Tris HC1/1 5 mm EDTA, pH 7.4). The
weight of the entire tumour was recorded
before a representative section of the tumour
was cut and fixed in 10% neutral buffered
formalin for pathological examination. When
the tumour appeared grossly heterogeneous,
more than one area was sampled and fixed.
Fixed tissues were embedded in paraffin,
sectioned at 6 ,tm and stained with haemat-
oxylin and eosin.
The tumours were evaluated morpho-
logically, using the criteria for rat tumours
presented by Young and Hallowes (1973).
The percentage of neoplastic tissue was
estimated from areas of the tumour sections,
after excluding the connective tissue capsule
and large foci ofnecrosis, since these elements
were eliminated before assay ofthe oestrogen-
binding capacity.
The oestrogen-binding capacity was
determined on small fragments of tumour
from which the connective tissue capsule
and necrotic tissue had been removed.
Whenever possible, these fragments were
taken from tissue adjacent to the portion
fixed for pathological examination. How-
ever, when the tumours were small or
predominantly necrotic, all tissues which
appeared viable were pooled for analysis.
The assay was performed after administration
of [2,4,6,7-3H] oestradiol-17B (105 Ci/mmol;
New England Nuclear Corp., Boston, Mass.)
in vivo and/or in vitro, by sucrose density
centrifugation as described earlier (Boylan
and Wittliff, 1975). S.c. injections of 0-2 jug
(3H)-oestradiol-17B were made in the mid-
ventral area 30 min before killing. Since
this dose of hormone did not saturate the
available cytoplasmic binding sites, cytosols
prepared from these tumours were incubated
with (3H)-oestradiol-17B at a final concen-
tration of 3-5 nm before centrifugation.
Total binding capacity was expressed as
the sum of fmol (3H)-oestradiol-17B bound
per mg cytosol protein by cytosol saturated
in vitro plus that in the nuclear extract.
For assay in vitro, ligand was added to
cytosol prepared from tumours not exposed
to (3H)-oestradiol-17B in vivo.
RESULTS
Tumour incidence and di8tribution
Of 52 animals treated with DMBA,
46 (88%) developed at least one tumour;
multiple tumours were very common.
Although adenocarcinomas and fibro-
adenomas were most common, tumours
of several other origins were observed.
The distribution of 80 tumours in 27
animals was examined: (1) tumours were
equally distributed on the left and right
sides; and (2) evenly distributed among
three general body regions: .head and
neck, 31%; axilla, 33%; inguinal and
anal, 35%.
Mammary adenocarcinomas
The Table includes data from 20
adenocarcinomas arising in 13 rats all
of which had ovariectomy at least 3 days
before being killed. The total oestrogen-
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TABLE.-Morphology, Growth Characteristics, and Oestrogen-binding Capacity of 20
DMBA-induced Mammary Adenocarcinomas
Time of
Behaviour after
ovariectomy
Spontaneous regression
? Spontaneous regression
? Early regression
? Early regression
Spontaneous regression
Steady growth
Regression
Steady growth
Static
Steady growth
Static
Steady regression
Steady growth
Steady regression
Regression and regrowth
Regression and regrowth
Regression and regrowth
Regression and regrowth
Regression and regrowth
Oestrogen-
binding
capacity
(fmol/mg
protein)
Diagnosis
(and comments)
37 A (many ducts and
alveoli)
74 A (many ducts and
papillary)
3 A (variable cribiform
pattern)
3 A (variable, many alveoli)
7 A (variable, many alveoli)
9 A (many ducts)
57 C (anaplastic)
18 A (ducts and alveoli)
14 A (many ducts)
24 C (comedo pattern)
67 A (many ducts)
7a A (many alveoli)
6 A (low grade)
2 A (spindle cell very
infiltrative)
10 A (comedo pattern)
10 A (many ducts and
alveoli)
5 A (variable)
22 A (many ducts)
21 A (variable-half alveoli
half ducts)
4 A (low grade)
appearance
Neoplastic after last
part of DMBA
tumour treatment
(%) (days)
75 28
85 63
85 42
70
85
75
85
75
90
25
80
60
75
70
80
50
50
80
80
50
56
56
56
91
35
56
42
56
56
70
49
b
35
42
42
56
56
a Estimated from data in vivo.
b Tumour discovered at sacrifice.
A = Adenocarcinoma.
C = Cribiform carcinoma.
binding capacity of the tumours varied
both between animals and between tu-
mours from the same animal, ranging
up to 74 fmol (3H) oestradiol-17B bound
per mg cytosol protein.
These 20 tumours were discovered
between 28 and 91 days after the final
intubation of DMBA, with the exception
of tumour lOB, which was discovered
at the time of killing, 166 days after the
final intubation. From these data, there
does not appear to be a statistically
significant relationship between OBC and
the time of appearance of these tumours
(regression analysis: b, 0.488). Like-
wise, no relationship was seen between
OBC and the time between ovariectomy
and killing (b 04196).
Five tumours removed from animals
killed between 74 and 111 days showed re-
growth after regression (Fig. 1). The
OBC of these tumours ranged from 4
to 22 fmol/mg cytosol protein. Variation
in binding capacity was also found in
tumours whose size did not change after
ovariectomy (range: 6-67 fmol/mg cytosol
protein) or which regressed steadily in
size after ovariectomy (range: 2-74 fmol/
mg cytosol protein).
The regressing and regrowing tumours
had the same variable morphological
appearance as the other tumours, but
had more mitoses in areas that were
evidently the site ofrenewed proliferation.
One of the regrowing adenocarcinomas
proved to be a mixture of fibroadenoma
and adenocarcinoma and another had
areas of sebaceous differentiation.
The amount of viable neoplastic tissue
in the adenocarcinomas ranged from 25
Time after
ovariectomy
Tumour
33C
4A
30A
30C
30B
49A
2A
27E
IIF
IIA
lIE
20A
41B
1OA-2
lOB
52A
52B
37A
42A
42B
at assay
(days)
3
4
6
6
6
12
12
14
17
17
17
25
40
60
60
74
74
82
111
111
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FiG.l.-Growth profiles of 2 tumours (52A * 0; 52B O) from the same animal, illustrat-
ing the phenomenon of a second growth phase after an initial decrease in average diameter following
ovariectomy ( ) of the host.
to 90%. No statistical correlation was
demonstrated between OBC and the
percentage of neoplastic tissue in each
tumour (r =0028).
An attempt was made to correlate
many of the histological features of the
adenocarcinomas with the OBC, time
between ovariectomy and killing, and
growth characteristics following ovariec-
tomy. The numbers of mitoses which
characterized the majority of the tumour
tissue available for histological examina-
tion were categorized as " many ", " mod-
erate " or "few". The OBC of the
tumours with more mitoses was generally
lower than in those with fewer mitoses.
Three of the 11 tumours with moderate
or large numbers of mitoses had OBC
values >10, while 6/9 tumours with few
mitoses had OBC values > 10. The
tumours showing regression and regrowth
had more mitotic figures than those with
steady growth. The time between ovari-
ectomy and killing had little bearing on
the number of mitoses found in the
tumours. For example, in tumours with
moderate numbers of mitoses, some were
removed only 6 days after ovariectomy,
while one was removed as much as 111
days after ovariectomy. There was a
definite tendency for tumours removed
from the same animal to have a similar
mitotic index. All 3 tumours from Ani-
mal 30 had moderate numbers of mitoses,
while all 3 from Animal 11 had few.
Eleven of the 20 tumours possessed
moderate to marked stromal inflamma-
tion (Fig. 2). The OBC of these 11
tumours varied between 3 and 74 fmol/mg
cytosol protein and there appeared to
be no correlation. The tumours that
showed only regression had more inflam-
mation (7/9) than those with static or
steady growth, or regression followed by
regrowth (4/10). There also appeared to
be a correlation between the presence
of moderate or marked inflammation
and the time following ovariectomy when
2
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initially after ovariectomy. The OBC
varied from 4 to 74 fmol/mg cytosol
protein and the interval between ovariec-
tomy and killing varied from 4 to 111
days. There appeared to be no cor-
relation with these parameters.
Five of the 20 tumours removed at
the time ofkilling had much lipid (Fig. 3).
The OBC of these tumours ranged from
3 to 57 fmol/mg cytosol protein. How-
ever, 4/5 had OBC <1O fmol/mg cytosol
protein. The time after ovariectomy
varied from 6 to 111 days, and the growth
characteristics on the 4 for which it
was known varied from regression only to
steady growth.
Another histological feature prominent
in some of the adenocarcinomas was
cyst formation, in which homogeneous
acidophilic material was found (Fig. 2).
This was particularly prominent in 10
FIG. 2.-Prominent stromal inflammation in
DMBA-induced-mammaryadenocarcinoma.
Some large cysts (bottom) contain acido-
philic material. H. and E., x 250.
the interpretation was made (date of
killing). Of the 11 tumours with mode-
rate to marked inflammation in the
stroma, the average time between ovariec-
tomy and killing was 22-9 days, whereas
for the 9 tumours with little or no stromal
inflammation, the average length of time
was 62-4 days. There appeared to be
little variation in the amount of inflam-
mation seen in the different tumours from
any one animal: e.g., 2/3 tumours from
Animal 11, and 3/3 tumours from Animal
30 had marked inflammation, while both
the tumours from Animals 10 and 42
had little or no inflammation.
Eight of the adenocarcinomas had
many mast cells in the stroma, sometimes
accompanying the inflammation described
above. Except for one tumour whose FIG. 3.-Lipid-containing adenocarcinoma
size remained unchanged, all these tu- juxtaposed to fibroadenoma from rat in which tumour was regrowing after post- mours were regressing or had regressed ovariectomyregression. H. andE. x 100.
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spindle-shaped carcinoma cells. One of
the hard nodules (IOA-i) was diagnosed
as an extra-osseous osteosarcoma (Fig. 4).
Three other adenocarcinomas in this
study had areas of squamous metaplasia.
Tumour 42B, located in the inguinal
area, appeared uniform on gross examina-
tion, but was found to consist of both
adenocarcinoma and fibroadenoma with
intermingled borders (Fig. 3). At the
time of killing, this tumour had entered
a new phase of growth following initial
regression after ovariectomy. The OBC
of this composite tumour was 4 fmol/mg
cytosol protein.
Tumour 44A was diagnosed as a
sebaceous basal-cell carcinoma and was
located in the right inguinal region. The
growth of this tumour was ovary-inde-
pendent and it had an OBC of 9 fmol/mg
cytosol protein. One of the tumours
FIG. 4.-Osteosarcoma in mammary gland,
adjacent to DMBA-induced mammary
adenocarcinoma. H. and E. x 400.
of the 20 tumours. No correlation could
be found with the OBC (range 3 to 67
fmol/mg cytosol protein) interval between
ovariectomy and killing (range 6 to 82
days) or growth characteristics (3 re-
mained static or grew, 4 regressed only,
and 2 regressed and regrew: one was
found at killing).
Mixed mammary tumours and tumours of
other origin
Four of the 35 tumours examined
histologically were composed of adeno-
carcinomas mixed with tumours of other
origins. Tumour IOA was grossly het-
erogeneous, containing small hard nodules
within soft, well-vascularized tissue. The
soft tissue, designated IOA-2, bound 2
fmol [3H] oestradiol-17B/mg cytosol pro-
tein and was diagnosed as a very infiltra- FIG. 5. Squamous andsebaceous differentia-
tive adenocarcinoma with many mitotic tioninadenocarcinomaarisingfromZymbal gland in DMBA-treated rat. H. and E. figures, some duct formation, and many x250.
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included in the study (52B) which regrew
after regression, had areas of sebaceous
differentiation and had an OBC of 5
fmol/mg cytosol protein.
Three tumours located on the dorso-
lateral surface of the head near the ear
were diagnosed as highly keratinizing
squamous carcinomas with areas of seba-
ceous differentiation (Zymbal gland tu-
mours) (Fig. 5). All lacked demonstrable
EBC both in vivo and in vitro: their
growth was totally ovary-independent.
DISCUSSION
The oestrogen-binding capacity and
growth characteristics of a number of
DMBA-induced mammary adenocarcino-
mas in ovariectomized rats were com-
pared with the morphology of these
neoplasms. OBC failed to correlate with
most ofthe parameters evaluated, namely,
time of appearance of the tumours after
DMBA administration, the interval be-
tween ovariectomy and analysis, the
growth characteristics of the tumours
after ovariectomy, or the amount of
viable neoplastic tissue, stromal inflam-
mation, or number of mast cells in the
tumours. The OBC of tumours with
more mitoses was generally lower than
that found in tumours with few mitoses,
probably due to the decreased differentia-
tion in the 9 rapidly proliferating tumours.
However, 4/5 tumours with much lipid
had an OBC <10 fmol/mg cytosol protein.
While the presence of concentrations of
lipid usually reflects a considerable degree
of differentiated function, this aspect of
cell activity does not appear to be cor-
related with high levels of oestrogen-
binding proteins. During a study of
tumour regression, Gullino et al. (1972)
found that DMBA-induced tumours ac-
cumulated triglycerides soon after ovari-
ectomy. However, this does not account
for the high lipid content in the 5 tumours
discussed here, since one showed steady
growth for 40 days after ovariectomy,
and another tumour had regressed, and
then entered a new phase of growth.
Further analysis of the relation of lipid
content to other aspects of tumour-cell
function is necessary.
The lack of correlation between OBC
and the percentage of neoplastic cells
indicates that these cells have concentra-
tions of oestrogen-binding proteins which
may be very different from tumour to
tumour. In the transition to malignancy,
cells of different tumours appear to
retain a variable ability to produce
oestrogen-binding proteins. This contrasts
with the relatively constant level of
OBC characterizing the transplantable
R3230AC rat mammary tumour (Boylan
and Wittliff, 1973; Wittliff et al., 1972).
The lack of correlation between OBC and
the interval between ovariectomy and
analysis would indicate that the ovaries
alone are not necessary to maintain a
significant population ofoestrogen-binding
proteins in these tumours.
Takizawa et al. (1974) reported that
most DMBA-induced tumours disappeared
almost completely by 3 weeks after
ovariectomy, whereas Dao (1964) reported
that many tumours that initially regress
following endocrine organ ablation begin
to regrow after 2 months, but not to the
extent they did before ablation. Five
of the 20 tumours in this investigation
showed some regrowth after regression,
if they were allowed to remain in the
host beyond 60 days after ovariectomy.
The fibroadenoma found in one of these
5 regrowing tumours, and the sebaceous
differentiation found in another, may
indicate that the regrowth resulted from
an entirely different tumour type from
the original adenocarcinoma that re-
gressed after ovariectomy.
Tumours other than adenocarcinomas
have been described previously in rats
administered DMBA (Dao, 1964; Huggins,
Grand and Brillantes, 1961; Middleton,
1965). However, to our knowledge, extra-
osseous osteosarcomas have not been
reported previously arising in rats given
DMBA at any age, even though sarcoma-
like transformation has been reported
in poorly differentiated DMBA-induced
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adenocarcinomas (Archer and Orlando,
1968).
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